In addition to its San Gabriel store, the company also owns and operates an online store based in the free trade zone of Shanghai, China.
Articles
India Globalization Capital (NYSE: IGC) Shows Potential for Strong Market Valuation Growth
India Globalization Capital, Inc. (NYSE MKT: IGC), a Maryland-based company, is currently preparing four products for medical trials, including Hyalolex for the treatment of Alzheimer’s disease.
India Globalization Capital’s (NYSE: IGC) Cannabis Drug Development for Alzheimer’s Backed by Previous Studies
Its drug development pipeline consists of treatments for seizures, neuropathic pain, and eating disorders, but one gaining attention is an experimental cannabis-based drug for Alzheimer’s disease, IGC-AD1.
InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Enters Research and Development Collaboration with ATERA SAS
Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced its entry into a research and development collaboration with ATERA SAS of France, a leading tissue engineering company specializing in the development of advanced human tissue models.
India Globalization Capital, Inc. (NYSE: IGC) Developing Phytocannabinoid-Based Product Pipeline to Treat Two- and Four-Legged Alike
Looking to gain an advantageous foothold in the burgeoning medical marijuana market, India Globalization Capital, Inc. (NYSE MKT: IGC) is developing innovative cannabis-based combination therapies that have application for both humans and animals.
Marijuana Industry Growth Fueled by Investments and Public Support for Legalization
With the market expanding and public support increasing, there are more opportunities to invest than ever before.
InMed Pharmaceuticals, Inc. (IMLFF) Gains Attention for Its Operational Developments and Leadership Team
InMed Pharmaceuticals, Inc. (OTCQB: IMLFF), a pre-clinical stage biopharmaceutical company that specializes in the development of therapies through research and development into the pharmacology of cannabinoids and drug delivery systems, continues to get positive media coverage of ongoing operational developments, propelled by the company’s impressive leadership team.
Algae Dynamics Corp. (ADYNF) Continues Cannabis Oil Research as Potential Marijuana Shortage Looms in Canada
Investors have had their eyes on Algae Dynamics Corp. (OTCQB: ADYNF), which has partnered with various Canadian universities (including the University of Waterloo and Western University) for access to research and to boost its cannabis extraction expertise.
Chineseinvestors.com, Inc. (CIIX) Taking Aim at Emerging Cannabidiol Markets of Mainland China
Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.
ChineseInvestors.com, Inc. (CIIX) Executes a First to Market Milestone
A population of over 1.2 billion people is one heck of a target market, especially when insulated by language. ChineseInvestors.com (OTCQB: CIIX) has leveraged this demographic to market a broad range of products, services and information specifically for the Chinese speaking population.
India Globalization Capital, Inc. (NYSE: IGC) Taps Dr. Craig Cheifetz as Advisor for Clinical Trials of Cannabis-Based Combination Therapies
India Globalization Capital, Inc. (NYSE MKT: IGC) has named Craig Cheifetz, M.D., as an advisor to aid the company in its clinical trials in microbiology, immunology, neuroscience, and biotechnology.
India Globalization Capital (NYSE: IGC) Strategically Staking Claims in the Medical Marijuana Markets
India Globalization Capital (NYSE MKT: IGC) formerly mined and converted low-grade iron ore to high-grade ore until prices plummeted. It was then that company management made the decision that to preserve shareholder value it must change course.
7 Company Updates from this Week to Review
Although the marijuana industry is comprised of some incredible companies, investors must be selective and focus on the real players.
India Globalization Capital, Inc. (NYSE: IGC) From Mining to Marijuana
At first blush, India Globalization Capital (NYSE: IGC) would seem a curiosity clothed in an enigma. Just how does a NYSE company move from a successful mining orientation to a pioneer in the development of multiple cannabinoid-based pharmaceutical therapies to treat pain and disease?
ChineseInvestors.com (CIIX) Helping Treat Patients with Amyotrophic Lateral Sclerosis
Also known as Lou Gehrig’s disease, ALS is a fatal illness that attacks the nerve cells that control voluntary muscles such as those in the face, arms, legs, and others.